Although much has been published on the potential risk of pancreatitis and pancreatic cancer from administration of GLP-1 mimetics, there have equally been studies which demonstrate no effects on this parameter [30]–[38]. This evidence concerns the gene GLP1R and familial pancreatic carcinoma.